Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity

Barbara Schmidt, Peter J Anderson, Lex W Doyle, Deborah Dewey, Ruth E Grunau, Elizabeth V Asztalos, Peter G Davis, Win Tin, Diane Moddemann, Alfonso Solimano, Arne Ohlsson, Keith J Barrington, Robin S Roberts, Caffeine for Apnea of Prematurity (CAP) Trial Investigators

Research output: Contribution to journalArticlepeer-review

230 Citations (Scopus)

Abstract

Very preterm infants are prone to apnea and have an increased risk of death or disability. Caffeine therapy for apnea of prematurity reduces the rates of cerebral palsy and cognitive delay at 18 months of age.
Original languageEnglish
Pages (from-to)275-82
Number of pages8
JournalJAMA : the journal of the American Medical Association
Volume307
Issue number3
DOIs
Publication statusPublished - 18 Jan 2012

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity'. Together they form a unique fingerprint.

Cite this